Senior Vice President, Operations and Finance

Brady joins Tentarix from Cidara Therapeutics (NASDAQ: CDTX), a publicly listed biotechnology company, where he held roles of increasing responsibility from 2015 to 2022, ultimately serving as Vice President of Finance and Principal Accounting Officer. Over the course of his tenure, Brady helped build and later lead the finance and accounting organization, supporting critical corporate initiatives including the company’s $76 million IPO and $74 million Series B financing in 2015. Altogether, he contributed to raising over $340 million in gross proceeds through public and private equity offerings and debt financings. He also played a key role in operationalizing strategic collaborations with Janssen Pharmaceuticals (a Johnson & Johnson company) and Mundipharma, representing over $1.3 billion in total potential deal value.

Brady began his career with Grant Thornton LLP and is a Certified Public Accountant in California. He holds both a Master’s and Bachelor’s degree in Accounting from the University of San Diego.